FDA
approval
· 2022-12-19
FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
Summary
FDA approved a supplemental application for Clozaril (clozapine) filed by HLS Therapeutics (USA), Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLOZARIL (CLOZAPINE)